Evidence of a founder BRCA1 mutation in Scotland

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 705-711

  Liede, A ^a   Cohen, B ^b   Black, D M ^c   Davidson, R H ^c   Renwick, A ^c   Hoodfar, E ^a   Olopade, O L ^d   Micek, M ^e   Anderson, V ^b   De Mey, R ^b   Fordyce, A ^b   Warner, E ^f   Dann, J L ^g   King, M C ^g   Weber, B ^h   Narod, S A ^a   Steel, C M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d The University of Chicago Medicine   (United States)

^e UNIVERSITY OF VICTORIA   (Canada)

^f DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer genetics; Breast ovarian cancer syndrome; Founder BRCA1 2 mutation; Founder effect; Genotype analysis; Scotland

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DATA BASE; FEMALE; GENE MUTATION; GENEALOGY; GENETIC EPIDEMIOLOGY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVARY CANCER; POPULATION GENETICS; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES;

EID: 0033967731     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0984     Document Type: Article

References (34)

1. BIC (1998) Breast Cancer Information Core Database: http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic/
2. Bodmer JG, Kennedy LJ, Lindsay J and Wasik AM (1987) Applications of serology and the ethnic distribution of three locus HLA haplotypes. Br Med Bull 43: 94-121
3. Boyd M, Harris F, McFarlane R, Davidson HR and Black DM (1995) A human BRCA1 gene knockout. Nature 375: 541-542
4. Claus EB, Schildkraut JM, Thompson WD and Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77: 2318-2324
5. Collyer S and De Mey R (1987) Public records and recognition of genetic disease in Scotland. Clin Genet 31: 125-131
6. Easton DF, Ford D and Peto J (1993) Inherited susceptibilily to breast cancer. Cancer Surv 18: 1-17
7. Easton DF, Ford D and Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265-271
8. Ford D, Easton DF, Bishop DT, Narod SA and Goldgar DE (1994) Risks of cancer in BRCA1 mutation carriers. Lancet 343: 692-695
9. Ford D, Easton DF and Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457-1462
10. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE and King M-C (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8: 399-404
11. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE and King M-C (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57: 1284-1297
12. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF and Ponder BAJ (1997) Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60: 1239-1242
13. IARC (1997) Cancer Incidence in Five Continents, Vol. VII. International Agency for Research on Cancer: Lyon
14. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V and Barkardottir RB (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56: 3663-3665
15. Lancaster JM, Carney ME, Gray J, Myring J, Gumbs C, Sampson J, Wheeler D, France E, Wiseman R, Harper P and Futreal PA (1998) BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1. Br J Cancer 78: 1417-1420
16. Liede A, Rehal P, Vesprini D, Jack E, Abrahamson J and Narod SA (1998) A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. Am J Hum Genet 60: 1543-1544
17. Liu CY, Flesken-Nikitin A, Li S, Zeng Y and Lee WH (1996) Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10: 1835-1843
18. Lyon RLL (1962) Huntington's chorea in the Moray Firth area. Br Med J i: 1301-1306
19. Mullen P, Miller WR, Mackay J, Fitzpatrick DR, Langdon SP and Warner JP (1997) BRCA1 5382insC in sporadic and familial breast and ovarian carcinoma in Scotland. Br J Cancer 75: 1377-1380
20. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King M-C and Goldgar DE (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58: 271-280
21. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG and King M-C (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J Am Med Assoc 279: 915-921
22. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. Journal of the National Cancer Institute 91: 943-949
23. Peelen T, van Vliet M, Petruj-Bosch A, Mieremet C, van den Ouweland AMW, Hoervorst F, Brohet R, Ligtenberg MJL, Teugels E, van der Luijt R, van der Hout AH, Gille JJP, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJW, Bakker MM, Willems HW, van der Looij E, Neyns B, Bonduelle M, Jansen R, Oosterwijk JC, Sijmons R, Smeets HJM, van Asperen CJ, Meijers-Heijboer H, Klijn JGM, de Greve J, King M-C, Menko FH, Brunner HG, Halley D, van Ommen G-JB, Vasen HFA, Cornelisse CJ, van't Veer LJ, de Knijff P, Bakker E and Devilee P (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60: 1041-1049
24. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, H.F.A. V, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen G-JB and Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17: 341-345
25. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BAJ and Olah E (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60: 1242-1246
26. Roa BB, Boyd AA, Vocik K and Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14: 185-187
27. Sinclair S (1990) Tracing your Scottish Ancestors: a Guide to Ancestry Research in the Scottish Record Office. HMSO: Edinburgh
28. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS and Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11: 198-200
29. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC and Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 336: 1401-1408
30. Szabo CI and King M-C (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60: 1013-1020
31. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H and Eyfjord JE (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60: 1079-1084
32. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Lynch HT, Lenoir GM, Narod SA and Garber JE (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2: 1179-1183
33. Tonin PN, Mes-Masson A-M, Futreal A, Morgan K, Mahon M, Foulkes WD, Cole DEC, Provencher D, Ghadirian P and Narod SA (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63: 1341-1351
34. Xu CF, Chambers JA, Nicolai H, Brown MA, Hujeirat Y, Mohammed S, Hodgson S, Kelsell DP, Spurr NK, Bishop DT and Solomon E (1997) Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 18: 102-110